In vitro invasion, sphere formation, and protection against thapsigargin-induced apoptosis were also promoted by HMGB1 and CML-HMGB1, but the effects were more pronounced with CML-HMGB1 (Figure 3C–E). The gene discussed is HMGB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.